Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,661 | -19,445 | -15,056 | -8,671 | -3,820 |
| Depreciation Amortization | 47 | 256 | 86 | 58 | 29 |
| Accounts payable and accrued liabilities | 586 | 179 | 758 | 514 | 180 |
| Other Working Capital | 273 | 966 | 3,872 | 2,817 | 73 |
| Other Operating Activity | -925 | 1,936 | 301 | 211 | 780 |
| Operating Cash Flow | $-3,680 | $-16,108 | $-10,039 | $-5,071 | $-2,758 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,359 | N/A | -1,262 | N/A |
| PPE Investments | 29 | 3,814 | 300 | N/A | N/A |
| Purchase Of Investment | -712 | N/A | -1,661 | 8,713 | -720 |
| Sale Of Investment | 598 | N/A | 9,082 | N/A | 407 |
| Purchase Sale Intangibles | 7 | -185 | -96 | -76 | -33 |
| Other Investing Activity | 7 | -185 | -96 | -76 | -33 |
| Investing Cash Flow | $-78 | $10,988 | $7,625 | $7,375 | $-346 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100 | 80 | 80 | 55 | N/A |
| Financing Cash Flow | $100 | $80 | $80 | $55 | $N/A |
| Beginning Cash Position | 27,053 | 32,093 | 32,093 | 32,093 | 32,093 |
| End Cash Position | 23,395 | 27,053 | 29,759 | 34,452 | 28,989 |
| Net Cash Flow | $-3,658 | $-5,040 | $-2,334 | $2,359 | $-3,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,680 | -16,108 | -10,039 | -5,071 | -2,758 |
| Capital Expenditure | N/A | -86 | 300 | N/A | N/A |
| Free Cash Flow | -3,680 | -16,194 | -9,739 | -5,071 | -2,758 |